14.02.2013
- Swiss group Actelion has raised its dividend 25% as it awaits a U.S. regulatory decision on a new heart and lung drug it hopes will cut its dependency on current mainstay Tracleer...
12.02.2013
- Novozymes Biopharma today announced a collaborative research agreement with Rhode Island-based biotech company EpiVax, to help further the development of a treatment for autoimmune...
11.02.2013
- Regeneron Pharmaceuticals said its longtime drug-development partner Sanofi aims to boost its stake in the U.S. biotechnology company through open market purchases of its stock...
07.02.2013
- Amgen said it expects generic versions of biotech drugs, known as biosimilars, to be a multibillion-dollar opportunity for the company and has targeted some of the industry's...
07.02.2013
- Amgen, the world's largest biotechnology company, on Thursday raised its 2013 earnings forecast to account for a Puerto Rico excise tax credit due to federal settlements for prior...
07.02.2013
- Swiss biotech group Basilea said its chief financial officer was leaving the company just two months after the departure of the firm's founder and chief executive. Joachim Blatter...
06.02.2013
- Biogen is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug...
04.02.2013
- Solvias announced the acquisition of Confarma, headquartered in Münchenstein, and its subsidiary Confarma France. Solvias, a pharmaceutical service provider, is pursuing a long...
